2010

Genzada stands for a small, but fiercely determined mindset of inspiration, invigorated by the origins of invention. Genzada believes there is no higher calling than to serve…

Outlook Therapeutics is a late clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a complex, technically challenging and commercially…

Rainier Therapeutics, Inc. is a privately-held, clinical stage biotechnology company developing a targeted biologic for the potential treatment of both early stage and metastatic…

Entera Bio is a product-focused biotechnology company specializing in the oral delivery of large molecules and biologics. Entera Bio is currently conducting clinical trials on its…

AB2 Bio Ltd., located at the Innovation Park of the École Polytechnique Fédérale de Lausanne (EPFL), is a drug discovery and development company focused on developing “best in…

Modra Pharmaceuticals is a clinical stage company that develops new treatment paradigms by enabling oral bioavailability of existing anticancer drugs to improve cancer therapy and…

Henlix Biotech Co., Ltd. engages in research and development of monoclonal antibody therapeutics, bi-specific antibodies, and antibody drug conjugates (ADCs).

Ultragenyx is a biopharmaceutical company committed to bringing to patients novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating…

Abzyme Therapeutics is a biopharmaceutical company focused on developing modular single domain VHH antibody fragments for immunotherapy using proprietary antibody generation…

MinervaX is pursuing the development of a novel vaccine candidate against Group B Streptococci (GBS).